Biotech Results from the Clinical Trial of Qilu Pharmaceutical’s Novel Anticancer Agent Iparomlimab and Tuvonralimab (QL1706) Featured in Oral Presentation at the ESGO Annual Meeting March 4, 2024
Health Procare Health: Silencing HPV infection may exacerbate the physiological effects of the emotional burden March 4, 2024
Oil & Gas SPARTAN DELTA CORP. ANNOUNCES 2023 YEAR-END RESULTS, RESERVES AND UPDATED GUIDANCE FOR 2024 February 27, 2024
Automotive L2+ Hands-off Assisted Driving Report 2024, with Profiles of Key Players APTIV, BMW, Bosch, Continental, Ford, GM, Mobileye, Nissan, NVIDIA, Qualcomm, Toyota & ZF February 9, 2024